Researchers assessed the efficacy and safety of IL-17 inhibitor brodalumab in patients with axial spondyloarthritis.
Researchers described driving difficulties among patients with axial spondyloarthritis and characterized clinical and sociodemographic features and impact on work.
Researchers evaluated gastrointestinal-related adverse events in patients with psoriatic arthritis and ankylosing spondylitis who were initiating secukinumab.
Researchers collected data on patient-reported outcome measures in spondyloarthritis from patients with psoriatic arthritis and ankylosing spondylitis.
A deep dive into the classification criteria, diagnosis, and implications for therapy in axial spondyloarthritis.
Researchers assessed the safety and efficacy of oral phosphodiesterase 4 inhibitor apremilast in patients with active ankylosing spondylitis.
Researchers assessed the prevalence of high disease activity, measured using ASDAS, in patients with ankylosing spondylitis with low BASDAI scores after anti-TNF treatment.
Researchers developed definitions for active and structural MRI lesions in the sacroiliac joint that were typical of axial spondyloarthritis.
Study authors assessed perception of sexual quality of life in men and women with axial spondyloarthritis, after a 5-year follow-up.
Researchers assessed the prognostic factors of postoperative outcomes for cervical spine fractures in patients with ankylosing spondylitis.